Global and China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Topical
1.2.3 Oral Therapy
1.3 Market by Application
1.3.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Dermatology And Podiatry Clinics
1.3.4 Independent Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Perspective (2015-2026)
2.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Growth Trends by Regions
2.2.1 Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Share by Regions (2015-2020)
2.2.3 Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Market Size
3.1.1 Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Revenue (2015-2020)
3.1.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Players (2015-2020)
3.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
3.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Concentration Ratio
3.4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue in 2019
3.5 Key Players Dermatophytic Onychomycosis Therapeutics (DOT) Area Served
3.6 Key Players Dermatophytic Onychomycosis Therapeutics (DOT) Product Solution and Service
3.7 Date of Enter into Dermatophytic Onychomycosis Therapeutics (DOT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatophytic Onychomycosis Therapeutics (DOT) Breakdown Data by Type (2015-2026)
4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Size by Type (2015-2020)
4.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Type (2021-2026)
5 Dermatophytic Onychomycosis Therapeutics (DOT) Breakdown Data by Application (2015-2026)
5.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Size by Application (2015-2020)
5.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2015-2026)
6.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020)
6.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020)
6.4 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2015-2026)
7.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020)
7.3 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020)
7.4 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2015-2026)
8.2 China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020)
8.3 China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020)
8.4 China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2015-2026)
9.2 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020)
9.3 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020)
9.4 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2015-2026)
10.2 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020)
10.3 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020)
10.4 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Details
11.1.2 Galderma Business Overview
11.1.3 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.1.4 Galderma Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020))
11.1.5 Galderma Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.2.4 Bausch Health Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
11.2.5 Bausch Health Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.3.4 Novartis Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.4.4 Pfizer Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
11.4.5 Pfizer Recent Development
11.5 Janssen
11.5.1 Janssen Company Details
11.5.2 Janssen Business Overview
11.5.3 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.5.4 Janssen Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
11.5.5 Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Topical
Table 4. Key Players of Oral Therapy
Table 5. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2015-2020)
Table 9. Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2021-2026)
Table 11. Dermatophytic Onychomycosis Therapeutics (DOT) Market Market Trends
Table 12. Dermatophytic Onychomycosis Therapeutics (DOT) Market Drivers
Table 13. Dermatophytic Onychomycosis Therapeutics (DOT) Market Challenges
Table 14. Dermatophytic Onychomycosis Therapeutics (DOT) Market Restraints
Table 15. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Players (2015-2020)
Table 17. Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) as of 2019)
Table 18. Global Dermatophytic Onychomycosis Therapeutics (DOT) by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatophytic Onychomycosis Therapeutics (DOT) Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Share by Type (2015-2020)
Table 24. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2021-2026)
Table 25. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Share by Application (2015-2020)
Table 26. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Share by Application (2021-2026)
Table 28. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2015-2020)
Table 30. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2015-2020)
Table 32. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2015-2020)
Table 34. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2015-2020)
Table 36. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2015-2020)
Table 38. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2015-2020)
Table 40. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 41. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2015-2020)
Table 42. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 43. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2015-2020)
Table 44. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (US$ Million) (2015-2020)
Table 45. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Region (2015-2020)
Table 46. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2015-2020)
Table 48. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2015-2020)
Table 50. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2015-2020)
Table 52. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2015-2020)
Table 54. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2015-2020)
Table 56. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2015-2020)
Table 58. Galderma Company Details
Table 59. Galderma Business Overview
Table 60. Galderma Product
Table 61. Galderma Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020) (US$ Million)
Table 62. Galderma Recent Development
Table 63. Bausch Health Company Details
Table 64. Bausch Health Business Overview
Table 65. Bausch Health Product
Table 66. Bausch Health Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020) (US$ Million)
Table 67. Bausch Health Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Product
Table 71. Novartis Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020) (US$ Million)
Table 72. Novartis Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Product
Table 76. Pfizer Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020) (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Janssen Company Details
Table 79. Janssen Business Overview
Table 80. Janssen Product
Table 81. Janssen Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020) (US$ Million)
Table 82. Janssen Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type: 2020 VS 2026
Figure 2. Topical Features
Figure 3. Oral Therapy Features
Figure 4. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Dermatology And Podiatry Clinics Case Studies
Figure 7. Independent Pharmacies Case Studies
Figure 8. Mail Order Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Dermatophytic Onychomycosis Therapeutics (DOT) Report Years Considered
Figure 11. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions: 2020 VS 2026
Figure 13. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2021-2026)
Figure 14. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Players in 2019
Figure 15. Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue in 2019
Figure 17. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Galderma Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
Figure 45. Bausch Health Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
Figure 46. Novartis Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
Figure 47. Pfizer Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
Figure 48. Janssen Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed